Abstract
Here we present a protocol for the isolation, purification, and inactivation of the yellow fever virus (YFV) aimed to facilitate high-resolution structure determination using cryo-electron microscopy (cryo-EM). Cryo-EM studies require the concentration of viral particles to be at least 1012 particle/mL. The concentration of the sample was evaluated by a combination of methods, including the plaque-forming assay, spectrophotometry, and protein polyacrylamide gel electrophoresis. High purity of the sample was confirmed by electrophoresis and transmission electron microscopy. The cryo-EM data set was collected and the 2D classification of viral particles was performed.
Similar content being viewed by others
REFERENCES
N. J. Barrows, R. K. Campos, K. Liao, et al., Chem. Rev. 118, 4448 (2018).
T. P. Monath, Antiviral Res. 78, 16 (2008).
K. V. Pugachev, F. Guirakhoo, D. W. Trent, and T. P. Monath, Int. J. Parasitol. 33, 567 (2003).
CDC, Yellow Fever Maps (2018, accessed on April 17, 2019. https://www.cdc.gov/yellowfever/maps/index.
C. Paules and A. S. Fauci, New Engl. J. Med. 376, 1397 (2017).
T. P. Monath, C. K. Lee, J. G. Julander, et al., Vaccine 14, 3827 (2010).
A. D. Barrett and D. E. Teuwen, Curr. Opin. Immunol. 21, 308 (2009).
M. Martin, T. F. Tsai, C. B. Cropp, et al., Lancet 358, 98 (2001).
P. F. Vasconcelos, E. J. Luna, R. Galler, et al., Lancet 358, 91 (2001).
R. C. Chan, D. J. Penney, D. Little, et al., Lancet 358, 121 (2001).
T. P. Pato, M. C. O. Souza, D. A. Mattos, et al., Vaccine 37, 3214 (2019).
D. Ruzek, Ž. T. Avšič, J. Borde, et al., Antiviral Res. 164, 23 (2019).
X. Zhang, R. Jia, H. Shen, et al., Viruses 9, 338 (2017).
M. Brecher, H. Chen, B. Liu, et al., PloS One 10, e0130062 (2015).
M. Bollati, K. Alvarez, R. Assenberg, et al., Antiviral Res. 87, 125 (2010).
F. A. Ray, K. Stiasny, M. Ch. Vaney, et al., EMBO Rep. 19, 206 (2018).
E. H. Egelman, Biophys. J. 110, 1008 (2016).
Y. Zhang, J. Corver, P. R. Chipman, et al., EMBO J. 22, 2604 (2003).
R. Stass, W. M. Ng, Y. Ch. Kim, et al., Adv. Virus Res. 105, 35 (2019).
M. Sevvana, F. Long, A. S. Miller, et al., Structure 26, 1169 (2018).
T. J. Chambers and M. S. Diamond, Adv. Virus Res. 60, 273 (2003).
L. J. Reed and H. Muench, Am. J. Epidemiol. 27, 493 (1938).
A. P. Ivanov, T. D. Klebleeva, and O. E. Ivanova, Vopr.Virusol. 65, 21 (2020).
M. Trauchessec, O. Lambert, P. Bonnafous, et al., Vaccine 37, 3580 (2019).
D. Tegunov and P. Cramer, Nat. Methods 16, 1146 (2019).
J. Zivanov, T. Nakane, B. Forsberg, et al., eLife 7, e42166 (2018).
R. C. Pereira, A. N. M. R. Silva, M. C. Souza, et al., Vaccine 33, 4261 (2015).
Sh. V. A. Coelho, S. R. L. Neris, M. P. Papa, et al., J. Virol. Methods 246, 65 (2017).
H. Toriniwa and T. Komiya, Biologicals 35, 221 (2007).
N. Mittereder, K. L. March, and B. C. Trapnell, J. Virol. 70, 7498 (1996).
ACKNOWLEDGMENTS
We are grateful to K.K. Tuchinskaya for discussion and valuable advice.
Funding
The study was supported by the Russian Foundation for Basic Research (project no. 18-02-40026).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated by T. Safonova
Rights and permissions
About this article
Cite this article
Pichkur, E.B., Samygina, V.R., Ivanova, A.L. et al. Preliminary Structural Study of Inactivated Yellow Fever Virus. Crystallogr. Rep. 65, 915–921 (2020). https://doi.org/10.1134/S1063774520060267
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1063774520060267